Pharmaceuticals
Category VIEW ALL
Roll-to-Roll Production of Smart Wound Dressings for Real-Time and Retrospective Monitoring
Technology No. 2025-LEE-71004
Novel peritoneal dialysis catheter design
Technology No. 2025-LEE-70820
Tumbling Microrobots for in vivo Targeted Drug Delivery
Technology No. 2025-CAPP-70958
Long Acting Buprenorphine Implants
Technology No. 2024-OTTE-70416
NIR Biosafe QR Codes with Bioinkjet Printing and Tagging
Technology No. 2024-KIM-70421
EpicPen: A Reusable and Re-settable Autoinjector
Technology No. 2023-WILL-70088
Laser-Assisted Modification of Titanium Implant Surfaces to Enhance Bone Cell Mineralization and Antimicrobial Properties
Technology No. 2022-RAHI-69768
OCULAR DRUG DELIVERY DEVICES AND METHODS OF USE THEREFORE
Technology No. 2022-LEE-69581
Cyber-physical Watermarking with Inkjet Edible Bioprinting
Technology No. 2022-KIM-69723
Microneedle Patch for Wound Oxygenation and Biofilm Eradication
Technology No. 2021-RAHI-69535
Magnetic Microactuator Enabled Self Clearing Catheter for Intraventricular Hemorrhage Treatment
Technology No. 2021-LEE-69527
Resorbable Surgical Mesh Impregnated with Calcium Peroxide
Technology No. 2020-RAHI-68984
Bioresorbable materials for unobtrusive, sustained topical delivery of therapeutics
Technology No. 2020-LEE-68893
"Sera" Child-Resistant Pill Organizer
Technology No. 2019-JUDG-68526
Chlorin Conjugates for Photodynamic Chemotherapy for Triple-Negative Breast Cancer
Technology No. 2023-ISAA-70121
Development of a novel cytokine-like Propeptide gene therapy platform
Technology No. 2023-FIGU-70017
Fluorescence-based Assay for Novel E3 Ligase Ligand Identification
Technology No. 2023-DAS-69989
Computational method for predicting protein function
Technology No. 2020-KIHA-68982
Fluorescent Assay for Determining Phosphoribosyl Ubiquitination
Technology No. 2020-DAS-69098
Discovery of HIV-1 Protease Inhibitors Using Imatinib/Nilotinib Templates for HIV/AIDS Treatment
Technology No. 2023-GHOS-70150
Repurposing Phenol/Phosphate Anticancer Drugs as Cationic Lipid Salts in SLNs: Focus on Etoposide
Technology No. 2023-BYRN-69951
Next generation SARS-CoV-2 vaccines for emerging variants
Technology No. 2025-MITT-71007
Unique Adenoviral Vector-Based Universal Influenza Vaccine
Technology No. 2025-MITT-70855
Synthetic DNA nanopores for transmembrane delivery of biological material
Technology No. 2025-GREE-70808
Rhodanine Linker Compounds for Inhibiting IAPP, α‑Synuclein, and Tau Aggregation with Fluorescent Probing of IAPP Fibrils
Technology No. 2025-FORT-70836
Amide‑Linked Coumarin Scaffolds Inhibit α‑Synuclein and Tau Aggregation for Neurodegenerative Drug Leads
Technology No. 2025-FORT-70835
Vascularized Neuroimmune Organoids with Patient Brain Homogenates for Alzheimer’s Research and Drug Discovery
Technology No. 2024-XU-70690
Discovery of small molecule benzothiazole and indole derivatives tackling Tau 2N4R and α-synuclein fibrils
Technology No. 2024-FORT-70558
Inhibitor against FicD/HYPE mediated AMPylation
Technology No. 2023-MATT-70064
Enzymatic Preparation of Small, Single-Stranded DNA Circles
Technology No. 2023-MAO-70050
Nanoparticle Formulation for Selective Delivery of Drugs to Cancer Cells
Technology No. 2023-HAN-70164
Materials to Contain the Norovirus from Emesis
Technology No. 2023-GOLD-69930
Urea-based Small Molecules Inhibit the Aggregation of Human and Feline Amylin for the Treatment of Type 2 Diabetes
Technology No. 2023-FORT-70255
Dithiourea Derivatives Inhibit Alpha-synuclein Oligomer and Fibril Formation
Technology No. 2023-FORT-70200
Evaluation of symmetric aminoindole-linked triazine for a dual effect on alpha-synuclein and tau isoform 2N4R fibrillization
Technology No. 2023-FORT-70004
Discovery of 4-aminoindole Carboxamide Derivatives to Curtail Tau Isoform 2N4R Oligomer and Fibril Formation
Technology No. 2023-FORT-69967
Isothiourea Catalyzed Stereoselective Glycosylation
Technology No. 2023-AXEL-70326
PLA-PCL Microsphere Formulation to Deter Abuse of Prescription Opioids by Smoking
Technology No. 2022-SOLO-69817
Screening New Drugs for Treatng Retinitis Pigmentosa
Technology No. 2022-LEUN-69895
Ligand Directed Tyrosine Conjugation on Proteins using Imine Mannich Electrophiles
Technology No. 2022-KRUS-69838
Methods for Treating Castration-Resistant Prostate Cancer
Technology No. 2022-KIM-69751
Selective Delivery of DNA Origami Nanostructures to Cancer Cells
Technology No. 2022-CHOI-69914
Novel Approach to Induce Protection against Respiratory Viruses
Technology No. 2021-MITT-69166
Affinity Labeling of DNA-linked Ligands for High Throughput Ligand Binding Assays
Technology No. 2021-KRUS-69176
Protein solids
Technology No. 2025-ZHOU-71177
Bacteriophage formulations
Technology No. 2025-ZHOU-70957
Gel forming polymers for improved oral peptide formulations
Technology No. 2025-TAYL-70925
Materials, methods and sampling devices for preserving and extracting extracellular vesicles in biofluids
Technology No. 2025-TAO-70811
MATERIALS AND METHODS FOR THE PRODUCTION OF PHENYLALANINE
Technology No. 2025-MORG-70934
Expressible HCV Nucleic Acid and Encoded Glycoprotein Antigens and Methods
Technology No. 2025-KUHN-71090
carbonic anhydrase leads for treatment of bacterial infections
Technology No. 2025-FLAH-71261
Scientific Bespoke Artificial Intelligence Agents Optimized for Research Goals
Technology No. 2025-CHOP-71024
Targeting Cdc14 phosphatase for anti-fungal agents
Technology No. 2024-ZHAN-70728
SHP2 Degraders for Anti-cancer Therapy
Technology No. 2024-ZHAN-70417
TC-PTP/PTPN2 Degraders for Cancer Immunotherapy
Technology No. 2024-ZHAN-70394
Engineered Polymeric Excipients for Enhancing the Stability of Protein Biologics
Technology No. 2024-WON-70668
Microwave Assisted Catalytic Amidation of Organic Amines with Carboxylic Acids
Technology No. 2024-THOM-70677
5-6-5/6 Scaffold as Selective Kinase Inhibitor Moiety with Low Activity Against Immune and Cardiovascular Anti-targets
Technology No. 2024-SINT-70378
5/6-5/6-Bisaryl Substituted with Saturated Cyclic Heterocycles as TAK1 Inhibitors
Technology No. 2024-SINT-70377
Discovery of cyclic peptide natural product inhibitors of free living amoeba
Technology No. 2024-PARK-70715
mRNA Delivered Cell-surface Targeted and Epitope-focused Glycoprotein Antigens for HCV Vaccine
Technology No. 2024-KUHN-70514
A Sperm Glycoprotein-based Contraceptive Vaccine
Technology No. 2024-HOGE-70624
Enhanced immunotherapy of "cold" solid tumors using Tumor tropic S. Typhimurium expressing anti-cancer proteins
Technology No. 2024-HE-70612
Analogs of Diphyllin
Technology No. 2024-DAVI-70723
Omics Automation using Large Language Models
Technology No. 2024-CHOP-70566
PTP1B/TC-PTP Dual Protein Degraders
Technology No. 2023-ZHAN-70087
Nanopuff: Albumin-coated siRNA-bound polydopamine nanoparticles
Technology No. 2023-YEO-70458
Combination of Phosphatidyl Serine Blockade and STING Stimulation for Cancer Immunotherapy
Technology No. 2023-YEO-70023
Excipient-Free Lyophilization of Aqueous Polymer Micelle Suspensions
Technology No. 2023-WON-69925
Precision 3D Printing Method for Customizable Pharmaceutical Mini-Tablets
Technology No. 2023-SUND-70094
3H-pyrazolo[4,3-f]quinoline-based Compounds as STING Antagonists
Technology No. 2023-SINT-70181
Inhibitors of Solvent Front Mutated RET Kinase
Technology No. 2023-SINT-70021
Cyclic Peptide Stimulators of the Proteasome
Technology No. 2023-PARK-70287
Software: The Utility of CDK9 Inhibitors for Restricting Bladder and Cervical Cancers in Human and Dog
Technology No. 2023-KAZE-70312
PRMT Inhibitors
Technology No. 2023-HUAN-70160
A Novel Nanoparticle Adjuvant for Cancer Vaccines
Technology No. 2023-HOGE-70112
Bacterial Carbonic Anhydrase Inhibitors with Improved Pharmacokinetics and Efficacy
Technology No. 2023-FLAH-70278
Covalent Inhibitors as Anti-malarial Agents
Technology No. 2023-FLAH-70246
Natural Product-Inspired Molecules for Covalent Inhibition of SHP2 Tyrosine Phosphatase
Technology No. 2023-DAI-70254
CAR-neutrophils Produced In Vivo to Treat Cancer
Technology No. 2023-BAO-70025
Treatment of Lowe Syndrome
Technology No. 2023-AGUI-69998
Nanoparticle-based Abuse Deterrent Formulations
Technology No. 2022-YEO-69643
Immunoactive Nanocarrier of Immunogenic Cell Death Inducers
Technology No. 2022-YEO-69546
Sequence-Controlled Aliphatic Copolyesters
Technology No. 2022-WON-69547
Continuous Flow Synthesis of Lorazepam
Technology No. 2022-THOM-69904
Plasticizers to Improve Release Performance of Amorphous Solid Dispersions
Technology No. 2022-TAYL-69586
Materials and Method to In Situ Isolate Phosphoproteins in Extracellular Vesicles and Exosome
Technology No. 2022-TAO-69815
Benzamide or N-hydroxybenzamide Kinase Inhibitors Derived from Doebner-Povarov Reaction
Technology No. 2022-SINT-69859
Nicotinamide-based Compounds as Potent Inhibitors of Translational- and Transcriptional-related Kinases
Technology No. 2022-SINT-69726
Enhanced Cell-potent Peptidomimetic Inhibitors for NTMT1/2
Technology No. 2022-HUAN-69636
PROTEIN:PROTEIN INTERACTION INHIBITORS
Technology No. 2022-HU-69918
Highly Efficient and Optically Active Synthesis of Crown-THF Ligand
Technology No. 2022-GHOS-69804
Potent 2420-Class of Protease Inhibitors for Treatment of COVID-19
Technology No. 2022-GHOS-69733
Potent Protease Inhibitors for Treatment of COVID-19
Technology No. 2022-GHOS-69724
Design and Synthesis of bi-aryl Methylated Lactam Derivatives to Inhibit the BRD7 Bromodomain Function in Prostate Cancer
Technology No. 2022-DYKH-69819
Cyanide Countermeasures
Technology No. 2022-DAVI-69921
Catalysis-Enabled Concise Total Synthesis of the Tricyclic Prostaglandin D2 Metabolite Methyl Ester
Technology No. 2022-DAI-69694
Inhibitors of Cyclic Mononucleotide and Cyclic Dinucleotide Phosphodiesterases
Technology No. 2021-SINT-69252
Antibiotic Discovery via BICyCLE (Biologically Inspired Chemically Created Leads)
Technology No. 2021-PARK-69383
Computational Method for Modeling Protein Assembly with More Than Two Protein Subunits
Technology No. 2021-KIHA-69437
Cell-potent and Selective Inhibitors for Nicotinamide N-methyltransferase
Technology No. 2021-HUAN-69352
COMPOUNDS FOR THE TREATMENT OF SARS
Technology No. 2021-GHOS-69511
Design and Synthesis of Novel SARS-CoV-2 3C Inhibitors
Technology No. 2021-GHOS-69510
Tris-Amide Based Novel Anti-COVID-19 Compounds
Technology No. 2021-GHOS-69492
MODIFIED Discovery of Potent anti-Mpro Inhibitors for Covid-19 Treatment using Alpha-ketoamide Derivatives
Technology No. 2021-GHOS-69205
Targeting BRAT1 with Curcusone Diterpenoids and Analogs for Cancer Treatment
Technology No. 2021-DAI-69235
Novel Amination Method for Medicinally Important Compounds
Technology No. 2021-DAI-69172
Single Crystal Matrix Isolation of Biopharmaceuticals for Enhanced Stability
Technology No. 2021-CHMI-69348
Novel inhalation formulations of polymyxins
Technology No. 2020-ZHOU-68990
Nano-composite Microparticles with Ivacaftor and Colistin
Technology No. 2020-ZHOU-68954
Quinolone-based Inhibitors of Lymphoid Tyrosine Phosphatase (PTPN22)
Technology No. 2020-ZHAN-68996
N-aryl oxamic acid based inhibitors for Mycobacterium Tuberculosis Protein Tyrosine Phosphatase B (mPTPB)
Technology No. 2020-ZHAN-68995
Griseofulvin Formulation for Therapy of Wet Macular Degeneration
Technology No. 2020-YEO-69132
Custom G4 Microarrays can Determine a Large-scale Ligand Binding Selectivity
Technology No. 2020-YANG-69054
Mixed Solvent Micelle Formulation Procedure
Technology No. 2020-WON-69093
Activity-Based Probes with Unnatural Amino Acids to Monitor the Proteasome in Live Cells
Technology No. 2020-TRAD-68937
Telescoped Continuous Flow Synthesis of an Alkynylnaphthyridine Anticancer Agent, HSN608
Technology No. 2020-THOM-69095
Monitoring ADME Proteins in Extracellular Vesicles for Drug Therapeutics
Technology No. 2020-TAO-69103
Cell Phone Integrated Paper Microfluidic Device for Colorimetric Multiplexed Detection of Analytical Targets
Technology No. 2020-STAN-68920
2,3-Disubstituted pyrido[3,4-b]pyrazine-containing Compounds as Kinase Inhibitors
Technology No. 2020-SINT-69073
Crystallization Method to Reduce Filtration Time of Agrochemicals
Technology No. 2020-NAGY-69085
Discovery of Potent Protease Inhibitors for Covid-19 Treatment using Specifically Designed Novel bis-amide Derivatives
Technology No. 2020-GHOS-69088
Discovery of Potent Anti-Mpro Inhibitors for Covid-19 Treatment using Alpha-ketoamide Derivatives
Technology No. 2020-GHOS-69045
Discovery of Potent Anti-Mpro Inhibitors for Covid-19 Treatment
Technology No. 2020-GHOS-69034
NOVEL COMPOUNDS FOR IMMUNOMODULATORY ACTIVITY
Technology No. 2020-CHOP-68949
Therapeutic Strategy by Drug Repositioning against Lowe Syndrome
Technology No. 2017-AGUI-67722
CryoAPEX Technique for Sub Cellular Preservation
Technology No. 2020-MATT-68979
Chiral Harmonophores for Alignment Detection Microscopy
Technology No. 2026-SIMP-71296
SOLVENT-DEPENDENT PREPARATION OF AMINE-BORANES VIA WATER-MEDIATED REACTION
Technology No. 2023-RAMA-70058
METHOD FOR REDUCTION OF CARBOXYLIC ACIDS WITH AMMONIA BORANE CATALYZED BY TITANIUM TETRACHLORIDE
Technology No. 2023-RAMA-70052
Fluxification: Interfacial Solute Flux Promotes Emulsification at the Water|Oil Interface
Technology No. 2023-DICK-70036
Monotrifluoroacetoxyborane-Amine Complexes for Reductive Amination and Reduction of Imines and Enamines
Technology No. 2022-RAMA-69902
CINCH - Controlled Ice Nucleation Charge Gas Humidifier
Technology No. 2021-ALEX-69302
Continuous Mycelium-Based Drug Production Using Self-Healing Solid-State Fermentation Technology
Technology No. 2025-PORT-70916
Machine Learning Analysis of Biotherapeutics
Technology No. 2024-ARDE-70506
Fungal Drug Discovery Platform based on Automated Recovery of Mycelial Exudate Compounds (MECs) in Mycoponic Bioproduction
Technology No. 2025-PORT-70929